The company has mentioned they are fully funded for this year. Rett Syndrome has been recently added to a list of conditions that can apply for a grant under the DoD program (Fragile X already there) not to mention the US Army has already committed 25m US for running the TBI/Concussion trials. If they are successful I don't see why they wouldn't continue with the funding.
Ann: Neuren Investor Presentation, 11 January 2016, page-10
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.03 |
Change
0.700(4.29%) |
Mkt cap ! $2.176B | |||
| Open | High | Low | Value | Volume |
| $16.49 | $17.21 | $16.44 | $11.40M | 677.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | $17.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.05 | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |